Table 3.
Comparison of Outcomes
| Outcomes | Oritavancin | Vancomycin | P Value |
|---|---|---|---|
| Unadjusted Outcomes | |||
| 30 day subsequent admission rates | 5.80% | 16.20% | .002 |
| Mean healthcare costs | $10 096 (8865) | $12 779 (28 773) | .30 |
| Adjusted Outcomes | |||
| 30 day subsequent admission rates | 6.10% | 16.20% | .003 |
| Mean healthcare costs | $12 695 | $12 717 | .98 |